Next week, AMBS/BD's LymPro numbers will be announced. Not too long after we will have a partnership, maybe even two (CLIA partner and pharma partner). Then revenue guidance.
MANF news moving more quickly now. Additional orphans, big pharma taking notice and AMBS working in J&J's garage.
we'll move past the LymPro uncertainty so naysayers can focus on something else to worry folks about. It's the circle of life.
News 
Market Data 
Discover 
AI
